Correlation Between Lamar Advertising and Takeda Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Lamar Advertising and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lamar Advertising and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lamar Advertising and Takeda Pharmaceutical, you can compare the effects of market volatilities on Lamar Advertising and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lamar Advertising with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lamar Advertising and Takeda Pharmaceutical.

Diversification Opportunities for Lamar Advertising and Takeda Pharmaceutical

-0.57

Correlation Coefficient

Lamar Advertising  Takeda Pharmaceutical

Excellent diversification

The 3 months correlation between Lamar and Takeda is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Lamar Advertising and Takeda Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and Lamar Advertising is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lamar Advertising are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of Lamar Advertising i.e., Lamar Advertising and Takeda Pharmaceutical go up and down completely randomly.

Pair Corralation between Lamar Advertising and Takeda Pharmaceutical

Assuming the 90 days trading horizon Lamar Advertising is expected to under-perform the Takeda Pharmaceutical. In addition to that, Lamar Advertising is 1.41 times more volatile than Takeda Pharmaceutical. It trades about -0.08 of its total potential returns per unit of risk. Takeda Pharmaceutical is currently generating about 0.08 per unit of volatility. If you would invest  1,300  in Takeda Pharmaceutical on December 28, 2024 and sell it today you would earn a total of  80.00  from holding Takeda Pharmaceutical or generate 6.15% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.41%
Values	Daily Returns

Lamar Advertising  vs.  Takeda Pharmaceutical

Lamar Advertising

Risk-Adjusted Performance

Very Weak

Over the last 90 days Lamar Advertising has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Takeda Pharmaceutical

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Takeda Pharmaceutical are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Takeda Pharmaceutical may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Lamar Advertising and Takeda Pharmaceutical

The main advantage of trading using opposite Lamar Advertising and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lamar Advertising position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.

The idea behind Lamar Advertising and Takeda Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.